1. Home
  2. CAN vs TRDA Comparison

CAN vs TRDA Comparison

Compare CAN & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • TRDA
  • Stock Information
  • Founded
  • CAN 2013
  • TRDA 2016
  • Country
  • CAN Singapore
  • TRDA United States
  • Employees
  • CAN N/A
  • TRDA N/A
  • Industry
  • CAN Semiconductors
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAN Technology
  • TRDA Health Care
  • Exchange
  • CAN Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • CAN 330.5M
  • TRDA 264.5M
  • IPO Year
  • CAN 2019
  • TRDA 2021
  • Fundamental
  • Price
  • CAN $0.66
  • TRDA $5.80
  • Analyst Decision
  • CAN Strong Buy
  • TRDA Strong Buy
  • Analyst Count
  • CAN 6
  • TRDA 3
  • Target Price
  • CAN $2.67
  • TRDA $25.67
  • AVG Volume (30 Days)
  • CAN 58.1M
  • TRDA 142.9K
  • Earning Date
  • CAN 08-14-2025
  • TRDA 08-12-2025
  • Dividend Yield
  • CAN N/A
  • TRDA N/A
  • EPS Growth
  • CAN N/A
  • TRDA N/A
  • EPS
  • CAN N/A
  • TRDA 0.61
  • Revenue
  • CAN $317,009,000.00
  • TRDA $172,220,000.00
  • Revenue This Year
  • CAN $115.67
  • TRDA N/A
  • Revenue Next Year
  • CAN $63.75
  • TRDA N/A
  • P/E Ratio
  • CAN N/A
  • TRDA $9.63
  • Revenue Growth
  • CAN 65.68
  • TRDA 5.74
  • 52 Week Low
  • CAN $0.53
  • TRDA $5.65
  • 52 Week High
  • CAN $3.27
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • CAN 42.69
  • TRDA 35.53
  • Support Level
  • CAN $0.65
  • TRDA $6.18
  • Resistance Level
  • CAN $0.71
  • TRDA $6.81
  • Average True Range (ATR)
  • CAN 0.09
  • TRDA 0.36
  • MACD
  • CAN -0.03
  • TRDA -0.01
  • Stochastic Oscillator
  • CAN 7.64
  • TRDA 14.06

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Share on Social Networks: